Synthesis Electronic Technology disclosed its 2026 interim report. First-half revenue was 216 million yuan, up 12.31 percent year on year, while net loss attributable to the parent was 31.11 million yuan, narrowing the loss by 47.10 percent, though the company remained in the red. Revenue from AI plus smart city business was 178 million yuan, up 24.97 percent year on year, with gross margin up 15.95 percentage points to 37.54 percent. Revenue corresponding to performance obligations not yet fulfilled at period-end was about 1.111 billion yuan. Smart healthcare revenue was only 19.39 million yuan, down sharply by 41.16 percent year on year, while identity authentication revenue was 16.07 million yuan with gross margin of just 6.32 percent. The company's cash and cash equivalents fell from 698 million yuan to 337 million yuan, shrinking by more than half in six months. Short-term borrowings rose from 101 million yuan to 152 million yuan. Net cash flow from operating activities was negative 347 million yuan. Inventories increased from 261 million yuan to 376 million yuan. Subsidiary Synthesis Medical posted a net loss of 13.46 million yuan, and Innowave posted a net loss of 6.05 million yuan, for a combined loss of nearly 20 million yuan. Related goodwill has cumulatively been impaired by 177 million yuan.
Shandong Synthesis Electronic Technology Co LtdInterim loss narrowed but cash halved, short-term borrowings up, operating cash flow deeply negative
Subsidiary posted net loss of 6.05 million yuan
Subsidiary posted net loss of 13.46 million yuan
